[HTML] nih.gov

[HTML][HTML] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies

Y Lin, X Wang, H Jin - American journal of cancer research, 2014 - ncbi.nlm.nih.gov
The epidermal growth factor receptor (EGFR) is a kind of receptor tyrosine kinase (RTK) that
plays a critical role in the initiation and development of malignant tumors via modulating …
被引用次数：247 相关文章
[PDF] e-century.us

[PDF][PDF] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies

Y Lin, X Wang, H Jin - e-century.us
The epidermal growth factor receptor (EGFR) is a kind of receptor tyrosine kinase (RTK) that
plays a critical role in the initiation and development of malignant tumors via modulating …

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.

Y Lin, X Wang, H Jin - American Journal of Cancer Research, 2014 - europepmc.org
The epidermal growth factor receptor (EGFR) is a kind of receptor tyrosine kinase (RTK) that
plays a critical role in the initiation and development of malignant tumors via modulating …

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies

Y Lin, X Wang, H Jin - American journal of cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
The epidermal growth factor receptor (EGFR) is a kind of receptor tyrosine kinase (RTK) that
plays a critical role in the initiation and development of malignant tumors via modulating …

EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.

Y Lin, X Wang, H Jin - American Journal of Cancer Research, 2014 - europepmc.org
The epidermal growth factor receptor (EGFR) is a kind of receptor tyrosine kinase (RTK) that
plays a critical role in the initiation and development of malignant tumors via modulating …